Home

News & Blog - health economics
Weekly digest: Vietnam fights resistance, improper hand washing, and new TB drug
14 Jun 2013
A roundup of news on drug resistance and other topics in global health.
Read more »
0 Comments
Posted by Suraj Pant
Tags: antibiotic use, antibiotics, developing, disease, drug development, drug resistance, HAIs, health, health economics, malaria ecology, new antibiotics, new drugs, prescribing, resistance, TB, transmission, trends
Weekly digest: New drug approval paths, a closer look at the NIH outbreak, and stories of TB
7 Jun 2013
A roundup of news on drug resistance and other topics in global health.An article in Livemint on drug resistance quotes CDDEP Director Ramanan Laxminarayan as saying, “The MDR-TB problem in India cannot be ignored unless we are prepared for an even bigger problem down the road." [Livemint]
Read more »
0 Comments
Posted by Suraj Pant
Tags: AMFm, antibiotic use, antibiotics, cost, costs, developing, disease, drug development, drug resistance, elimination, Gram negative, HAIs, health, health economics, India, new antibiotics, new drugs, prescribing, resistance, resistance policy, TB
Weekly digest: Fighting TB in India, how to defeat MRSA in hospitals, and antibiotic circuits
31 May 2013
A roundup of news on drug resistance and other topics in global health.
Read more »
0 Comments
Posted by Suraj Pant
Tags: antibiotic use, antibiotics, cost, costs, developing, disease, drug development, drug resistance, Gram negative, HAIs, health, health economics, India, MRSA, new antibiotics, new drugs, policy, prescribing, resistance, TB, trends
Weekly digest: Michael Pollan on resistance, the decline of malaria, and antimicrobial clay
24 May 2013
A roundup of news on drug resistance and other topics in global health.
Read more »
0 Comments
Posted by Suraj Pant
Tags: antibiotic use, antibiotics, disease, drug development, drug resistance, Gram negative, HAIs, health, health economics, malaria ecology, MRSA, new antibiotics, new drugs, prescribing, resistance, TB, trends
Weekly Digest: WHO approves semi-synthetic artemisinin, antibiotic preservation - a joint responsibility, and funding for AMFm
17 May 2013
A roundup of news on drug resistance and other topics in global health.Stressing the need to preserve the efficacy of antibiotics, CDDEP Director Ramanan Laxminarayan writes in CDC’s Safe Healthcare that “we are all responsible for whether future generations will have effective antibiotics.” [CDC]
Read more »
0 Comments
Posted by Suraj Pant
Tags: AMFm, antibiotic use, antibiotics, developing, disease, drug development, drug resistance, flu, health economics, India, MRSA, new antibiotics, new drugs, policy, prescribing, resistance, TB